Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis

Abroad (travel likely)RecruitingPHASE1

Conditions

Uveal Melanoma, Metastatic

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

St Vincents Hospital, Sydney, New South Wales, Australia
Contact: Study coordinator (Robert Kent) · svhs.cancerresearch@svha.org.au · 61293555611
Alfred Hospital, Melbourne, Victoria, Australia
Contact: Study coordinator (Mark Shackleton, MBBS PhD)

Study leads

Anthony Joshua, MBBS PhD FRACP
Principal Investigator
St Vinents Hospital sydney

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma

Uveal Melanoma · Melanoma · Metastatic Uveal Melanoma

Abroad (travel likely)RecruitingPHASE1

Harrison, United States · New York, United States

Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours

Advanced Solid Tumor · Uveal Melanoma, Metastatic · Cutaneous Melanoma

Abroad (travel likely)RecruitingPHASE1

Herlev, Denmark · Barcelona, Spain

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Metastatic Malignant Solid Neoplasm · Metastatic Melanoma · Pathologic Stage IIIC Cutaneous Melanoma AJCC v8

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Los Angeles, United States

A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma

Melanoma Metastatic · Uveal Melanoma, Metastatic · Mucosal Melanoma

Abroad (travel likely)RecruitingPHASE1

Melbourne, Australia · Melbourne, Australia